SURFACE ONCOLOGY, INC.
CIK 0001718108
Revenue (TTM)
$0
+1,016.5% YoY
Q2 Jul 2023
Net Income (TTM)
−$96.39M
+19.0% YoY
Q2 Jul 2023
EPS Diluted (TTM)
−$1.64
+35.6% YoY
Q2 Jul 2023
Gross Margin
—
Q2 Jul 2023
Operating Margin
—
Q2 Jul 2023
Net Margin
—
Q2 Jul 2023
Free Cash Flow (TTM)
−$81.62M
Q2 Jul 2023
Cash
$14.84M
Q2 Jul 2023
Total Debt
—
Q2 Jul 2023
Shares Outstanding
60.82M sh
Q2 Jul 2023